Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Cancer research and Cyclin-dependent kinase 6, with related work in Vascular endothelial growth factor A, Protein kinase B, PTEN. Notable publications include 'miR‐137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6', 'miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A', and 'miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells'.
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells
miR‐137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6
miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A
miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1
Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression